The PERT Study - Training Factors of PERformance and Injuries (PERT)
The goal of this observational study was to learn about injuries in professional football players and to find out whether daily monitoring data could help predict injuries. The study followed male players from the first team and the reserve team of a French first-division professional football club over one full competitive season.
The main questions were:
How often did injuries occur among players over the season? Which day-to-day changes in routinely monitored data were linked to the onset of a new injury (all injuries combined, intrinsic and extrinsic)? Were the results similar when looking only at intrinsic injuries?
Each day, the club's staff recorded each player's physical workload during training sessions and matches using tracking technology. Players also reported how they felt, including sleep, fatigue, mood, and pain. New injuries were recorded daily by the club's medical staff. Players took part through the club's usual daily monitoring, with no additional tests or visits.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (実際)
入学
連絡先と場所
研究場所
-
-
-
Clermont-Ferrand、フランス
- CHU de Clermont-Ferrand
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Male football players from the first team and the reserve team of a French first-division professional football club, followed over one full competitive season.
説明
Inclusion Criteria:
- Male football players belonging to the first team or the reserve team of the participating French first-division professional football club during the study season
Exclusion Criteria:
- Fewer than 20 days of available monitoring data during the season
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 観測モデル：COHORT
- 時間の展望：RETROSPECTIVE
グループ/コホートの数
コホートと介入
グループ/コホートグループ/コホート |
介入・治療介入・治療 |
|---|---|
|
Professional football players
Male players from the first team and the reserve team of a French first-division professional football club, followed daily over one full competitive season through the club's routine monitoring of external workload, self-reported wellness and injury status. |
No intervention was assigned. Data came from the club's usual daily monitoring: external workload measured by tracking technology during training sessions and matches, and self-reported sleep, fatigue, mood, pain and perceived intensity. |
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Injury prevalence and occurrence of new injuries
時間枠：Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
Daily injury status (non-injured or injured) recorded by the club's medical staff, used to describe season-long injury prevalence. |
Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
|
Player characteristics
時間枠：Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
Age (years), professional status (reserve team or professional), playing position (defender, midfielder or forward) and number of previous injuries (0, 1 or ≥2), examined as putative factors associated with injury occurrence. |
Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
|
External workload
時間枠：Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
Measured by tracking technology during training sessions and matches: match exposure (yes or no), session duration (minutes), total distance covered (km), number of accelerations and decelerations per day, distance covered (m) and number of sprints per day at 80-90% and 90-100% of each player's individual maximal speed. Examined as putative factors associated with injury occurrence. |
Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
|
Self-reported wellness and perceived exertion
時間枠：Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
Sleep time (hours/day), sleep quality (1 = best to 7 = worst), mood (1 = best to 7 = worst), fatigue (1 = min to 7 = max), pain (1 = min to 7 = max) and perceived exertion (1 = min to 10 = max). Examined as putative factors associated with injury occurrence. |
Daily from June 26, 2023, to May 19, 2024 (47 weeks).
|
協力者と研究者
捜査官
捜査官
- 主任研究者：Frédéric Dutheil、University Hospital, Clermont-Ferrand
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- 2023_DUTHEIL (PERT)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。